您的位置: 首页 > 农业专利 > 详情页

Imidazo[5,1-f][1,2,4]triazines for treatment of neurological disorders
专利权人:
Pfizer Inc.
发明人:
Chappie, Thomas Allen,Humphrey, John Michael,Verhoest, Patrick Robert,Yang, Eddie,Helal, Christopher John
申请号:
AU2012221828
公开号:
AU2012221828B2
申请日:
2012.02.09
申请国别(地区):
AU
年份:
2015
代理人:
摘要:
The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds as a method for the treatment of a disease or condition selected from the group consisting of central nervous system disorders, cognitive disorders, schizophrenia, dementia and other disorders in a mammal.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充